DexCom Inc. (DXCM) News
Filter DXCM News Items
DXCM News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
DXCM News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest DXCM News From Around the Web
Below are the latest news stories about DEXCOM INC that investors may wish to consider to help them evaluate DXCM as an investment opportunity.
DexCom stock rises on 2025 outlookDexCom (NASDAQ:DXCM) shares popped 6% premarket on Monday after the company set its financial forecast for 2025, projecting adjusted gross profit margin of around 64% – 65% on revenue of $4.60B ($4.60B Seeking Alpha | January 13, 2025 |
Why Is Jim Cramer Mystified by DexCom, Inc. (DXCM)’s Earnings Miss and Competitive Challenges?We recently published a list of Jim Cramer Discussed These 10 NASDAQ 100 Stocks Recently. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other NASDAQ 100 stocks that Jim Cramer discussed recently. Jim Cramer, the host of Mad Money, recently shared his perspective on the stock […] |
3 Beaten-Down Stocks That May Be Due for Big Comebacks in 2025The past year was a great one for the stock market as a whole, but there were plenty of companies that didn't do well in 2024. Shares of Celsius Holdings (NASDAQ: CELH), DexCom (NASDAQ: DXCM), and Nike (NYSE: NKE) all fell by more than 30% during the year, as investors weren't thrilled with their results. Energy drink company Celsius struggled last year as its growth rate nosedived. |
Dexcom to Present at 43rd Annual J.P. Morgan Healthcare ConferenceSAN DIEGO, January 07, 2025--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the 43rd annual J.P. Morgan Healthcare Conference on January 13, 2025. |
DexCom's (NASDAQ:DXCM) Returns On Capital Are Heading HigherWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? One common... |
These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024Now that we've shut the door on 2024, it's useful to look back at some of the best -- and, on the flip side, some of the worst -- performers of the year on the stock market. Many outliers were in the tech sector, so it's worth taking a look at the tech-heavy Nasdaq-100 index. In order from steepest decline to narrowest, the five unloved were Intel (NASDAQ: INTC), MongoDB (NASDAQ: MDB), Biogen (NASDAQ: BIIB), DexCom (NASDAQ: DXCM), and Microchip Technology (NASDAQ: MCHP). |
Abbott, Dexcom settle glucose monitor patent lawsuitsThe rival companies agreed not to sue each other for the next 10 years. |
The 5 worst performing stocks on the Nasdaq 100 in 2024AI was huge in 2024. The underperformers list reflects challenges in the other sectors. |
DexCom Insiders Sold US$18m Of Shares Suggesting HesitancyIn the last year, many DexCom, Inc. ( NASDAQ:DXCM ) insiders sold a substantial stake in the company which may have... |
At US$80.57, Is DexCom, Inc. (NASDAQ:DXCM) Worth Looking At Closely?Let's talk about the popular DexCom, Inc. ( NASDAQ:DXCM ). The company's shares received a lot of attention from a... |